Table 1 Participant characteristics at baseline
Enrolled; n = 17 n, (%) | |
|---|---|
Age | |
20–29 | 6 (35%) |
30–39 | 7 (41%) |
40–49 | 2 (12%) |
50+ | 2 (12%) |
Racial identity | |
American Indian/Native American | 1 (6%) |
White | 14 (82%) |
Other | 1 (6%) |
Prefer not to respond | 1 (6%) |
Ethnicity | |
Not Latinx | 16 (94%) |
Latinx | 1 (6%) |
Gender identitya | |
Female | 4 (23%) |
Male | 13 (77%) |
Education completed | |
Some high school | 3 (18%) |
High school or GED | 4 (23%) |
Any college | 10 (59%) |
Relationship status | |
Single/separated | 11 (65%) |
Married/partnered | 6 (35%) |
Employment | |
Working full-time | 3 (18%) |
Working part-time | 5 (29%) |
Student | 1 (6%) |
Disabled, unable to work | 1 (6%) |
Unemployed | 6 (35%) |
Stay at home parent | 1 (6%) |
Insurance coverage | |
Private | 3 (18%) |
Public | 1 (6%) |
None | 13 (76%) |
Had consistent access at home to | |
Computer with video camera | 6 (35%) |
Computer without video camera | 1 (6%) |
Smartphone | 17 (100%) |
Tablet | 1 (6%) |
Basic telephone (without internet capabilities) | 0 (0%) |
Had ever taken bup/nx prior to study enrollment | 16 (94%) |
Was on MOUD (bup/nx or methadone) in prior 12 months | 9 (53%) |
Obtained from provider | 6 (67%) |
Obtained from informal sourceb | 5 (56%) |
Had ever overdosed on heroin, fentanyl, or prescription pain medication | 9 (53%) |
Had heard of PrEP before | 12 (71%) |
Had ever taken PrEP prior to study enrollment | 1 (6%) |
Positive for hepatitis C antibodyc | 10 (63%) |